EMDR treatment for fear of cancer recurrence in familial melanoma patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of Eye Movement Desensitization and Reprocessing (EMDR) in reducing fear of cancer recurrence (FCR) among patients with familial melanoma. The study involves a randomized waiting-list control design, where eligible participants will receive up to four 90-minute EMDR sessions. The primary outcome will be measured using the Cancer Worry Scale (CWS), while quality of life will be assessed with the EORTC questionnaire. The trial aims to provide psychological support to patients who experience high levels of FCR, which can significantly impact their quality of life.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* a score of 16 or higher on the FCRI-NL-SF
* 18 years or older
* diagnosed with familial melanoma

Exclusion Criteria:

* insufficient knowledge of the Dutch language.
* acute psychiatric disease (psychosis, suicidal ideation)
* variable dosis of anxiolytics

Where it's running

• Leiden University Medical Center
  Leiden, South Holland, Netherlands Recruiting
• Leiden University Medical Centre
  Leiden, South Holland, Netherlands Recruiting

Study contacts

• Principal investigator: Chris Hinnen, Dr. — Leiden University Medical Centre
• Study coordinator: Sanne K. de Bie, Drs.
• Email: s.k.de_bie@lumc.nl
• Phone: 0031 71 526 3615

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Patient-partnered look at fear of cancer returning after kidney cancer surgery

  This project will work with people who had kidney cancer surgery and their partners to see if patient-led questions, timing, and digital methods can better identify fear that the cancer will come back.

  Recruiting at 3 sites Gødstrup Hospital · Aalborg and 2 other locations · NCT07234656

• Digital mindset training to improve half marathon performance

  This study is testing whether a short online training program can help recreational runners in New Zealand improve their half marathon performance by changing how they think about fatigue and soreness during their training.

  Recruiting University of Auckland, New Zealand · Auckland · NCT06972121

• Parent-FORT: Fear of Cancer Recurrence therapy for parents of childhood cancer survivors

  This pilot tests a virtual group therapy called Parent-FORT to see if it reduces fear of cancer recurrence and improves quality of life for parents of childhood cancer survivors.

  Recruiting University of Ottawa · Ottawa, Ontario · NCT06872840

• Adapted group cognitive-behavioral therapy for fear of cancer returning in women with BRCA1 or BRCA2 mutations

  This project tests an adapted group cognitive-behavioral therapy to reduce fear of cancer returning in women who carry BRCA1 or BRCA2 mutations and have finished primary treatment.

  Recruiting CHU de Quebec-Universite Laval · Québec, Quebec · NCT06817694

• Comparing two therapies for treating PTSD

  This study is testing which therapy works better for people with PTSD: eye movement desensitization and reprocessing or cognitive therapy, by giving 270 participants up to 24 weekly sessions of one of the two treatments.

  Recruiting Vestre Viken Hospital Trust · Drammen, Akershus · NCT06691347

• Evaluating a mental health support platform for university students

  This study tests whether a new mental health support platform for university students can improve their well-being compared to regular services.

  Recruiting Chinese University of Hong Kong · Hong Kong · NCT06623682

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.